Bryan Wahl - General Counsel at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
TARS on Nasdaq
All Insider Reports
All Insider Reports

Bryan Wahl - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Bryan Wahl for Tarsus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 51,712 $2,591,288 $50.11 20 Mar 2025 Direct
Restricted Stock Units 17,161 $277,483 $12.89 05 Mar 2026 Direct Common Stock
Stock Option (right to buy) 27,310 05 Mar 2026 Direct Common Stock

Transactions reported by Bryan Wahl for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.